Browse > Article

Comparison between the Calculated and Measured Doses in the Rectum during High Dose Rate Brachytherapy for Uterine Cervical Carcinomas  

Chung, Eun-Ji (Department of Radiation Oncology, National Health Insurance Corporation Ilsan Hospital)
Lee, Sang-Hoon (Department of Radiation Oncology, National Health Insurance Corporation Ilsan Hospital)
Publication Information
Radiation Oncology Journal / v.20, no.4, 2002 , pp. 396-404 More about this Journal
Abstract
Purpose : Many papers support a correlation between rectal complications and rectal doses in uterine cervical cancer patients treated with radical radiotherapy. In vivo dosimetry in the rectum following the ICRU report 38 contributes to the quality assurance in HDR brachytherapy, especially in minimizing side effects. This study compares the rectal doses calculated in the radiation treatment planning system to that measured with a silicon diode the in vivo dosimetry system. Methods : Nine patients, with a uterine cervical carcinoma, treated with Iridium-192 high dose rate brachytherapy between June 2001 and Feb. 2002, were retrospectively analysed. Six to eight-fractions of high dose rate (HDR)-intracavitary radiotherapy (ICR) were delivered two times per week, with a total dose of $28\~32\;Gy$ to point A. In 44 applications, to the 9 patients, the measured rectal doses were analyzed and compared with the calculated rectal doses using the radiation treatment planning system. Using graphic approximation methods, in conjunction with localization radiographs, the expected dose values at the detector points of an intrarectal semiconductor dosimeter, were calculated. Results : There were significant differences between the calculated rectal doses, based on the simulation radiographs, and the calculated rectal doses, based on the radiographs in each fraction of the HDR ICR. Also, there were significant differences between the calculated and measured rectal doses based on the in-vivo diode dosimetry system. The rectal reference point on the anteroposterior line drawn through the lower end of the uterine sources, according to ICRU 38 report, received the maximum rectal doses in only 2 out of the nine patients $(22.2\%)$. Conclusion : In HDR ICR planning for conical cancer, optimization of the dose to the rectum by the computer-assisted planning system, using radiographs in simulation, is improper. This study showed that in vivo rectal dosimetry, using a diode detector during the HDR ICR, could have a useful role in quality control for HDR brachytherapy in cervical carcinomas. The importance of individual dosimeters for each HDR ICR is clear. In some departments that do not have the in vivo dosimetry system, the radiation oncologist has to find, from lateral fluoroscopic findings, the location of the rectal marker before each fractionated HDR brachytherapy, which is a necessary and important step of HDR brachytherapy for cervical cancer.
Keywords
Cervical cancer; Radiotherapy; Brachytherapy; In vivo dosimetry;
Citations & Related Records
연도 인용수 순위
  • Reference
1 ICRU. Report 38: Dose and volume specification for reporting intracavitary thherapy in gynecology. International Commission on Radiation Units and Measurements, Bethesda. USA, 1985
2 CIark BG, Souhami L, Roman TN. Rectal complications in patients with carcinoma of the cervix treated with concomitant cisplatin and external beam irradiation with high dose rate brachytherapy: A dosimetric analysis. Int J Radiat Oncol Biol Phys 1994;28:1234-1250
3 Van Lancker M, Storme G. Prediction of severe late complications in fractionated, high dose-rate brachytherapy in gynecological applications. Int J Radiat Oncol Biol Phys 1991;20:1125-1129   DOI   PUBMED   ScienceOn
4 Perez CA, Grigsby PW, Lockett MA, et aI. Radiation therapy morbidity in carcinoma of the uterine cervix: Dosimetric and cIinical correlation. Int J Radiat Oncol Biol Phys 1994;44:855-866
5 JoeIsson I and Backstom A. Dose rate measurements in bladder and rectum. Acta Radiologica 1969;8:343-359
6 Orton CG, WoIf-RosebIum W. Dose dependence of compIication rates in cervix cancer radiotherapy. Int J Radiat Oncol Biol Phys 1986;12:37-44   DOI   PUBMED   ScienceOn
7 Lahtinen T, Tenhunen M, Vayrynen M. ICRU reference points and maximum doses of rectum and bladder in intracavitary radiotherapy. Radiother Oncolo 1993;28:174-176   DOI   ScienceOn
8 Kapp KS, StueckIschweiger GF, KappDS, et aI. Dosimetry of intracavitary placements for uterine and cervical carcinoma: Results of orthogonal film, TLD, and CT-assisted techniques. Radiother Oncol 1992;24:137-146   DOI   ScienceOn
9 UtIey JF, Von Essen CF, Horm RA et aI. High dose rate afterloading brachytherapy in carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 1984;10:2259-2263   DOI   ScienceOn
10 JosIin CAF. High-activity source afterloading in gynecologic cancer and its future prospects. Endocurie Hypertherm Oncol 1989;5:69-81
11 Hoskin PJ, Cook M, BouscaIe D, CansdaIe J. Changes in applicator position with fractionated high dose rate gynaecological brachytherapy. Radiother Oncol 1996;40:59-62   DOI   ScienceOn
12 Pourquier H, DuboisJB, DeIard R. Cancer of the uterine cervix: Dosimetric guidelines for prevention of late rectal and rectosigmoid conplications as a result of radiotherapeutic treatment. Int J Radiat Oncol Biol Phys 1982;8:1887-1895   DOI   PUBMED   ScienceOn
13 AIecu R and AIecu M. In vivo rectal dose measurements with diodes to avoid misadministrations during intracavitary high dose rate brachytherapy for carcinoma of the cervix. Med Phys 1999;26:768-770   DOI   ScienceOn
14 Cunningham DE, Stryker JA, VeIkIey DE. Routine cIinical estimation of rectal, rectosigmoidal and bladder doses from intracavitary brachytherapy in the treatment of carcinoma of the cervix. Int J Radiat Oncol Biol Phys 1987;7:653-660
15 Crook JM, Esche BA, ChapIain G, et aI. Dose-volume analysis and the prevention of radiation sequelae in cervical cancer. Radiother Oncol 1987;8:321-332   DOI   ScienceOn
16 Deshpande DD, Shrivastav SK, Pradhan AS, et aI. Dosimetry of intracaritary applications in carcinoma of the cervix: Rectal dose analysis. Radiother Oncol 1997;42:163-166   DOI   ScienceOn
17 WiIIiamson JF, EzzeII GA, OIch A et aI. Quality assurance for high dose rate brachytherapy, high dosr rate brachytherapy, edited by S Nag, Futura, Armonk, NY, 1994;147-215
18 Meertens HA. Comparison of dose calculation points around an intracavitary cervix application. Radiother Oncol 1989;115:199-206
19 Esche BA, Crook JM, Isturiz J, Horiot JC. Reference volume, milligranhours and external irradiation for the Fletcher applicator. Radiother Oncol 1987;9:255-261   DOI   ScienceOn
20 Potter R, Limbergen EV, Gerstner N, Wambersie A. Survey of the use of the ICRU 38 in recording and reporting cervical cancer brachytherapy. Radiother Oncol 2001;58:11-18   DOI   ScienceOn
21 Montana GS and FowIer WC. Carcinoma of the cervix: Analysis of bladder and rectal radiation dose and complications. Int J Radiat Oncol Biol Phys 1989;16:95-100   DOI   ScienceOn
22 Kessaris N, Nori D. Rectal thermoluminescent dosimeter measurements using the MicroSelectron high dose rate afterloader in postoqerative intravaginal radiation cases. Int J Radiat Oncol Biol Phys 1993;28:174-176